A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer
Clinical trial NCT00001498 · COMPLETED
Trial details
- NCT number
- NCT00001498
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1996-02-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.